Conv. Plasma
Nigella Sativa
Peg.. Lambda

All vitamin D studies
Meta analysis
Home COVID-19 treatment researchVitamin DVitamin D (more..)
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta
Cannabidiol Meta Molnupiravir Meta
Colchicine Meta
Conv. Plasma Meta
Curcumin Meta Nigella Sativa Meta
Ensovibep Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Peg.. Lambda Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Ivermectin Meta
Lactoferrin Meta

All Studies   Meta Analysis   Recent:  
0 0.5 1 1.5 2+ Symp. case 34% Improvement Relative Risk Vitamin D for COVID-19  Bhat et al.  Prophylaxis Is prophylaxis with vitamin D beneficial for COVID-19? Prospective study of 580 patients in India Fewer symptomatic cases with vitamin D (p=0.011) Bhat et al., J. Infection, March 2023 Favors vitamin D Favors control

Effect of calcifediol supplementation as add-on therapy on the immune repertoire in recipients of the ChAdOx1 nCoV-19 vaccine: A prospective open-label, placebo-controlled, clinical trial

Bhat et al., Journal of Infection, doi:10.1016/j.jinf.2023.03.004, CTRI/2021/08/035709
Mar 2023  
  Source   PDF   All Studies   Meta AnalysisMeta
Prospective study of 580 ChAdOx1 recipients, 262 treated with calcifediol (patient choice), showing lower cases with treatment. Supplementation did not significantly affect antibody levels following ChAdOx1 receipt. Calcifediol patients were older (31 vs. 26 in the exposed subgroup containing most patients). 50μg/day calcifediol.
This is the 108th of 116 COVID-19 controlled studies for vitamin D, which collectively show efficacy with p<0.0000000001 (1 in 38 sextillion). 28 studies are RCTs, which show efficacy with p=0.0000081.
risk of symptomatic case, 34.2% lower, RR 0.66, p = 0.01, treatment 59 of 262 (22.5%), control 52 of 152 (34.2%), NNT 8.6.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Bhat et al., 6 Mar 2023, prospective, placebo-controlled, India, peer-reviewed, 13 authors, dosage calcifediol 50μg days 1-180, trial CTRI/2021/08/035709.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperVitamin DAll
Abstract: Journal of Infection xxx (xxxx) xxx–xxx Contents lists available at ScienceDirect Journal of Infection journal homepage: Letter to the Editor Effect of calcifediol supplementation as add-on therapy on the immune repertoire in recipients of the ChAdOx1 nCoV-19 vaccine: A prospective open-label, placebo-controlled, clinical trial Dear Editor, Coronavirus disease 2019 (COVID-19) has caused formidable global health crisis, and multiple vaccination programs have been rolled out to curb the spread of the pandemic. Genetic disorders like primary immunodeficiency diseases severely compromise the gen­ eration of protective immunity following vaccinations. The spectrum also includes those genetic disorders that have a lesser impact on immunological memory such as Down Syndrome (DS). In a recent study, Valentini et al.1 confirmed that the serological efficacy of COVID-19 vaccination is least affected by DS. The authors included a substantial number of subjects and further observed that the older subjects exhibit lower anti-SARS-CoV-2 antibody titers 6 months after vaccination. Earlier, Yarci-Carrion et al.2 had also reported that DS and non-DS subjects develop similar anti-SARS-CoV-2 titers after the third dose of vaccine that decline with age. However, the same group demonstrated that DS subjects develop milder T cell responses to the standard 2-dose vaccine.3 Valentini et al.1 further denote that the factors modifying immune responses to vaccination in such disorders are less explored. This may include nutritional deficiencies like vitamin D [25(OH)D]. Indeed, reports have shown that hypovi­ taminosis D is quite frequent in subjects with DS.4 It is also known that individuals with low 25(OH)D levels have a higher risk of acquiring severe COVID-19 and stimulation of vitamin D receptor can reduce COVID-19-associated hospitalization and mortality.5,6 However, studies on vitamin D supplementation in COVID-19 vaccination have yielded conflicting results with some reporting improvement, while others observing lack of association between 25(OH)D status and antibody titers post vaccination.7,8 Most of these studies, however, did not assess cellular immune re­ sponses, which are more likely to be influenced by vitamin D. Cal­ cifediol [25(OH)D3], the immediate precursor of 1,25(OH)2D3 leads to a faster achievement of desired levels and biodistribution of cir­ culating 1,25(OH)2D3 as compared to cholecalciferol (vitamin D3).9 There are reports on favorable outcomes of calcifediol supple­ mentation in COVID-19,10 but there are no data on its utility in im­ proving efficacy of COVID-19 vaccines. Therefore, we evaluated the efficacy of calcifediol supplementation on cell-mediated immune responses besides anti-SARS-CoV-2 titers post COVID-19 vaccina­ tion. We carried an open-label, placebo-controlled clinical trial to assess the impact of calcifediol supplementation on the efficacy of ChAdOx1 nCoV-19 vaccine in terms of, protection from break­ through infection and COVID-19 disease, anti-SARS-CoV-2 antibody titers, SARS-CoV-2 specific lymphocyte proliferation and cytokine secretion. Herein 580 adult subjects receiving ChAdOx1 nCoV-19 vaccine were recruited at the Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India. The subjects received either calcifediol (50 µg/day) or placebo, orally for 6 months (Supplementary Fig. 1, Supplementary Table 1) and divided in 3 groups [SARS-CoV-2 unexposed,..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop